These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11390592)

  • 1. Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications.
    Hodges BL; Evans HK; Everett RS; Ding EY; Serra D; Amalfitano A
    J Virol; 2001 Jul; 75(13):5913-20. PubMed ID: 11390592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
    Hodges BL; Serra D; Hu H; Begy CA; Chamberlain JS; Amalfitano A
    J Gene Med; 2000; 2(4):250-9. PubMed ID: 10953916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
    Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
    Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
    J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors.
    Everett RS; Hodges BL; Ding EY; Xu F; Serra D; Amalfitano A
    Hum Gene Ther; 2003 Dec; 14(18):1715-26. PubMed ID: 14670123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
    Oualikene W; Lamoureux L; Weber JM; Massie B
    Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
    Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
    J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent mice.
    Hu H; Serra D; Amalfitano A
    Hum Gene Ther; 1999 Feb; 10(3):355-64. PubMed ID: 10048388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
    Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H
    Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of multiply deleted adenovirus vectors to probe adenovirus vector performance and toxicities.
    Amalfitano A
    Curr Opin Mol Ther; 2003 Aug; 5(4):362-6. PubMed ID: 14513678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy.
    Amalfitano A; Chamberlain JS
    Gene Ther; 1997 Mar; 4(3):258-63. PubMed ID: 9135740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
    Song W; Kong HL; Traktman P; Crystal RG
    Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus.
    Bourbeau D; Lau CJ; Jaime J; Koty Z; Zehntner SP; Lavoie G; Mes-Masson AM; Nalbantoglu J; Massie B
    Cancer Res; 2007 Apr; 67(7):3387-95. PubMed ID: 17409449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes.
    Marienfeld U; Haack A; Thalheimer P; Schneider-Rasp S; Brackmann HH; Poller W
    Gene Ther; 1999 Jun; 6(6):1101-13. PubMed ID: 10455413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
    Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of life cycle defective adenovirus mutants for production of adeno-associated virus vectors.
    Krüger-Haag A; Lehmann C; Schmidt E; Sonntag F; Hörer M; Kochanek S
    J Gene Med; 2019 Jun; 21(6):e3094. PubMed ID: 31037799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors.
    Everett RS; Evans HK; Hodges BL; Ding EY; Serra DM; Amalfitano A
    Virology; 2004 Jul; 325(1):96-105. PubMed ID: 15231389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene.
    Korst RJ; Ailawadi M; Lee JM; Lee S; Yamada R; Mahtabifard A; Crystal RG
    Hum Gene Ther; 2001 Sep; 12(13):1639-49. PubMed ID: 11535167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of transgene expression in cell cultures and in the mouse by replication-incompetent adenoviruses harboring modified VAI genes.
    Eloit M; Adam M; Gallais I; Fournier A
    J Virol; 1997 Jul; 71(7):5375-81. PubMed ID: 9188608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.